Horizon Therapeutics PLC (HZNP)
68.99
-0.05 -0.07%
NASDAQ
Nov 25, 14:16
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 1.819B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 3.66 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 792.01M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 76.20% |
| Profit Margin (Quarterly) | 46.01% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0% |
| Price and Valuation | |
| Market Cap | 15.23B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 8.360 |
| PE Ratio | 18.85 |
| Price to Book Value | 4.010 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.2641 |
| Free Cash Flow (Quarterly) | 95.43M |
| Return on Equity | Upgrade |
View All HZNP News
News
-
WireHeadlineTime (ET)
-
Yahoo11/25 08:00
-
MT Newswires11/23 10:01
-
PR Newswire11/23 08:00
-
Yahoo11/19 13:03
-
Yahoo11/18 10:11
-
Yahoo11/17 09:15
-
Yahoo11/16 10:54
-
Yahoo11/13 10:40
-
Yahoo11/13 10:31
-
Yahoo11/13 08:30
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 02/26/2021 | Earnings | Horizon Therapeutics PLC Fourth Quarter Earnings for 2020 Release |
| 02/26/2021 08:00 EST | Misc | Horizon Therapeutics PLC Fourth Quarter Earnings Conference Call for 2020 |
| 11/02/2020 | Earnings | Horizon Therapeutics PLC Third Quarter Earnings Result for 2020 |
| 11/02/2020 08:00 EST | Misc | Horizon Therapeutics PLC Third Quarter Earnings Conference Call for 2020 |
| 08/05/2020 08:00 EDT | Misc | Horizon Therapeutics PLC Second Quarter Earnings Conference Call for 2020 |
| 08/05/2020 | Earnings | Horizon Therapeutics PLC Second Quarter Earnings Result for 2020 |
| 05/06/2020 08:00 EDT | Misc | Horizon Therapeutics PLC First Quarter Earnings Conference Call for 2020 |
| 05/06/2020 | Earnings | Horizon Therapeutics PLC First Quarter Earnings Result for 2020 |
| 04/30/2020 | Misc | Horizon Therapeutics PLC Annual General Meeting for 2019 |
| 02/26/2020 08:00 EST | Misc | Horizon Therapeutics PLC Fourth Quarter Earnings Conference Call for 2019 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: https://www.horizonpharma.com
- Investor Relations URL: http://ir.horizon-pharma.com/
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Drug Manufacturers - General
- Equity Style: Mid Cap/Growth
- Next Earnings Release: Feb. 26, 2021
- Last Earnings Release: Nov. 02, 2020
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Horizon Therapeutics PLC is a specialty and generic drug manufacturing company. The company is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. The company has two reportable segments: orphan and rheumatology segment and the inflammation segment. It markets medicines in the areas of orphan diseases, rheumatology and inflammation division. The majority of revenue is generated in the United States.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 68.99 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| JCNRX | Janus Henderson Contrarian R | 4.74% |
| PTH | Invesco DWA Healthcare Momentum ETF | 3.75% |
| WSMRX | William Blair Small-Mid Cap Growth R6 | 3.28% |
| FXH | First Trust Health Care AlphaDEX® ETF | 1.69% |
| IBB | iShares Nasdaq Biotechnology ETF | 1.64% |
| HRAYX | Carillon Eagle Mid Cap Growth Y | 1.54% |
| HQH | Tekla Healthcare Investors | 1.34% |
| JGMCX | Janus Henderson Triton C | 1.27% |
| VISGX | Vanguard Small Cap Growth Index Inv | 0.91% |
| VBK | Vanguard Small-Cap Growth ETF | 0.91% |
| NAESX | Vanguard Small Cap Index Inv | 0.42% |
| VB | Vanguard Small-Cap ETF | 0.42% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- HZNP Tweets Stocktwits
Advertisement
